Gf Fund Management Co. Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.97 Trillion
- Q2 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,817 shares of XERS stock, worth $31,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,817
Previous 3,817
-0.0%
Holding current value
$31,986
Previous $21 Million
14.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
207Shares Held
89.4MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$86.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$82.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$32.1 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$31.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$30.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.14B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...